Evaluation of the Alcohol Elimination Effect of TCI711 Probiotic (Bacillus Coagulans) on Adult Individuals
NCT ID: NCT04457661
Last Updated: 2021-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2020-07-13
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
BC179 Relieves Discomfort After Drinking
NCT06899620
Bioavailability of Anthocyanins From Aronia Extract in Healthy Men - a Pilot Study
NCT04645394
The Effect of Avnace eZZe on Sleep Improvement
NCT07172607
The Effects of Chicken Extract on Mental Energy in Healthy Adults and the Underlying Mechanisms
NCT06021223
Effect of Acute Supplementation (taurine) on Maximal Strength and Anaerobic Power
NCT06884566
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TCI711 probiotic
Taking one capsule (containing 10\^10 of Bacillus coagulans TCI711) daily for one month
Bacillus coagulans TCI711
Using Bacillus coagulans TCI711 for one month and implementing alcohol testing at weeks 0, 1, and 4.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bacillus coagulans TCI711
Using Bacillus coagulans TCI711 for one month and implementing alcohol testing at weeks 0, 1, and 4.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Systolic pressure below 140
* Score of C-CAGE Questionnaire below 8 (male)/6 (female)
* Prohibiting other supplements before 2 weeks of the study and during the study
* Prohibiting alcohol drinks before 24 hours of the study
* Prohibiting caffeine drinks before 12 hours of the study
Exclusion Criteria
* Liver, kidney, cardiovascular, or chronic diseases
* Other severe disorders
* Hypertension
* Pregnancy or lactation
* Already involved in clinical testing
* Other supplements
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TCI Co., Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GeNext
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-036-A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.